martes, 6 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 24, 2026

Is Shopify (SHOP) Now Fairly Priced After Recent Share Price Pullback?

View original at finance.yahoo.com
Is Shopify (SHOP) Now Fairly Priced After Recent Share Price Pullback? Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • At ~$103 per share, Shopify trades at roughly a 3.6% discount to its DCF intrinsic value, indicating it is approximately fairly valued

    60% confidence

  • Analyst estimates and Simply Wall St extrapolations project Shopify's FCF to reach $6.4 billion by 2030

    60% confidence

  • Shopify's DCF intrinsic value is approximately $106.79 per share using a 2-Stage Free Cash Flow to Equity model

    60% confidence

  • Shopify receives a value score of 1 out of 6 on Simply Wall St's valuation checks

    60% confidence

  • Simply Wall St is trusted by over 7 million individual investors worldwide

    60% confidence

  • Shopify's 1-year stock return is +1.5%, 3-year return is +73.8%, and 5-year return is -17.1%

    60% confidence

  • Shopify's latest twelve month Free Cash Flow is approximately $2.1 billion

    60% confidence

Data points we hold from this source

Shopify Inc. · cash2.1 USD
Shopify Inc. · stock price103 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Is Shopify (SHOP) Now Fairly Priced After Recent Share Price Pullback? — Source | Via News | es.VIA.NEWS